|
- 积分
- 0
- 威望
- 0
- 包包
- 330
|
1、Activation of coagulation and fibrinolysis in patients with lung cancer: relation to tumour stage and prognosis
5 l# S$ c5 t- P- l4 Xhttp://www.ncbi.nlm.nih.gov/pubmed/8388741
/ g3 Q* X9 Q3 i2、Tissue factor antigen levels in various biological fluids# H: O6 X0 \# u, @3 C1 D& z
http://www.ncbi.nlm.nih.gov/pubmed/7647218& a2 x9 H$ p8 E9 ?9 y, s) k, \* T
3、Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers.
( @6 N- E, h% g& A0 n3 @$ p0 fhttp://www.ncbi.nlm.nih.gov/pubmed?term=Vascular%20endothelial%20growth%20factor%20(VEGF-A)%20plasma%20levels%20in%20non-small%20cell%20lung%20cancer%3A%20relationship%20with%20coagulation%20and%20platelet%20activation%20markers.% B9 R5 o- ]; I+ V$ q/ t+ A
4、The changes of blood coagulation in surgical patients with lung cancer1 I/ \8 W1 ~/ s8 z. b m
http://www.ncbi.nlm.nih.gov/pubmed?term=The%20changes%20of%20blood%20coagulation%20in%20surgical%20patients%20with%20lung%20cancer |
|
发表于 2011-8-8 12:15
